89929-27-1

Basic information

• Product Name: 9,10-dihydroxy-3-isobutyl-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one
• Synonyms: 9,10-dihydroxy-3-isobutyl-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one;2-Oxo-3-isobutyl-9,10-dihydroxy-1,2,3,4,6,7-hexahydro-11bH-benzochinolizin
• CAS NO: 89929-27-1
• Molecular Formula: C17H23NO3
• Molecular Weight: 289.36942
• EINECS: -0
• Mol File: 89929-27-1.mol
• Article Data: 2

Chemical Properties

• Melting Point: 195 °C
• Boiling Point: 483.4±45.0 °C(Predicted)
• Appearance: /
• Density: 1.24±0.1 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 9.98±0.40(Predicted)
• CAS DataBase Reference: 9,10-dihydroxy-3-isobutyl-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 9,10-dihydroxy-3-isobutyl-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one(89929-27-1)
• EPA Substance Registry System: 9,10-dihydroxy-3-isobutyl-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one(89929-27-1)

Safety Data

• Hazardous Substances Data: 89929-27-1(Hazardous Substances Data)

Usage

General Description

The chemical "9,10-dihydroxy-3-isobutyl-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one" is a complex organic compound that belongs to the class of isoquinoline alkaloids. It consists of a pyridoisoquinoline skeleton with a dihydroxy group at the 9th and 10th positions and an isobutyl group at the 3rd position. 9,10-dihydroxy-3-isobutyl-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one is synthesized from natural sources and has been found to possess various pharmacological activities, including anticancer, antimicrobial, and anti-inflammatory properties. It has potential therapeutic applications in the treatment of various diseases and disorders, making it an important compound in medicinal chemistry research.

Upstream product

• 58-46-8 (3R^*,11bR^*)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzoquinolizin-2-one 
• 1069-62-1 trimethyl[2-(2-methylpropyl)-3-oxobutyl]azanium iodide 
• 1187-87-7 5-methyl-3-methylidenehexan-2-one 

Downstream Products

• 1221885-59-1 deutetrabenazine 
• 718635-93-9 tetrabenazine 
• 58-46-8 (3R^*,11bR^*)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzoquinolizin-2-one 

Relevant articles and documents

Novel Process for Preparation of Tetrabenazine and Deutetrabenazine

A novel process for the synthesis of tetrabenazine (1) and deutetrabenazine (2), two well-known drugs used for the treatment of chorea associated with Huntington's disease, has been developed. All of the reaction parameters were optimized through a series of reactions and by using Design of Experiment techniques. The newly developed methods are industrially scalable and employ cheap, commercially available raw materials and hence are highly efficient. The added advantage is that the developed processes evade the use of genotoxic alkylating agents and therefore could be considered as safe and viable alternatives to the existing methods.